<?xml version='1.0' encoding='utf-8'?>
<document id="24950332"><sentence text="Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering."><entity charOffset="42-50" id="DDI-PubMed.24950332.s1.e0" text="tyrosine" /></sentence><sentence text="ABL1 tyrosine-kinase inhibitors (TKI) are front-line therapy for chronic myelogenous leukaemia and are among the best-known examples of targeted cancer therapeutics"><entity charOffset="5-13" id="DDI-PubMed.24950332.s2.e0" text="tyrosine" /></sentence><sentence text=" However, the dynamic uptake into cells of TKIs of low molecular weight and their intracellular behaviour is unknown because of the difficulty of observing non-fluorescent small molecules at subcellular resolution" /><sentence text=" Here we report the direct label-free visualization and quantification of two TKI drugs (imatinib and nilotinib) inside living cells using hyperspectral stimulated Raman scattering imaging"><entity charOffset="89-97" id="DDI-PubMed.24950332.s4.e0" text="imatinib" /><entity charOffset="102-111" id="DDI-PubMed.24950332.s4.e1" text="nilotinib" /><pair ddi="false" e1="DDI-PubMed.24950332.s4.e0" e2="DDI-PubMed.24950332.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24950332.s4.e0" e2="DDI-PubMed.24950332.s4.e1" /></sentence><sentence text=" Concentrations of both drugs were enriched over 1,000-fold in lysosomes as a result of their lysosomotropic properties" /><sentence text=" In addition, low solubility appeared to contribute significantly to the surprisingly large accumulation of nilotinib"><entity charOffset="108-117" id="DDI-PubMed.24950332.s6.e0" text="nilotinib" /></sentence><sentence text=" We further show that the lysosomal trapping of imatinib was reduced more than tenfold when chloroquine is used simultaneously, which suggests that chloroquine may increase the efficacy of TKIs through lysosome-mediated drug-drug interaction in addition to the commonly proposed autophagy-inhibition mechanism"><entity charOffset="48-56" id="DDI-PubMed.24950332.s7.e0" text="imatinib" /><entity charOffset="92-103" id="DDI-PubMed.24950332.s7.e1" text="chloroquine" /><entity charOffset="148-159" id="DDI-PubMed.24950332.s7.e2" text="chloroquine" /><pair ddi="false" e1="DDI-PubMed.24950332.s7.e0" e2="DDI-PubMed.24950332.s7.e0" /><pair ddi="false" e1="DDI-PubMed.24950332.s7.e0" e2="DDI-PubMed.24950332.s7.e1" /><pair ddi="false" e1="DDI-PubMed.24950332.s7.e0" e2="DDI-PubMed.24950332.s7.e2" /><pair ddi="false" e1="DDI-PubMed.24950332.s7.e1" e2="DDI-PubMed.24950332.s7.e1" /><pair ddi="false" e1="DDI-PubMed.24950332.s7.e1" e2="DDI-PubMed.24950332.s7.e2" /></sentence><sentence text="" /></document>